Healthcare & Life Sciences News and Articles

Google News – Pharmaceuticals External News

How America Can Reduce Its Dependence on Chinese Active Pharmaceutical Ingredients (APIs) - Information Technology and Innovation Foundation

news.google.com · 31 Aug 2026

Industry News External News

Forget GLP-1 stocks, baldness drugs are Wall Street’s next gold mine - The Japan Times

news.google.com · 31 Aug 2026

Google News – FDA (biotech/pharma) External News

Cipla Pharma license cancellation: FDA withdraws order after HC raps it for going 'overboard' - pharma.economictimes.indiatimes.com

news.google.com · 31 Aug 2026

Google News – FDA (biotech/pharma) External News

US FDA approves Takeda, Protagonist's drug for rare blood cancer - pharma.economictimes.indiatimes.com

news.google.com · 31 Aug 2026

Google News – Pharmaceuticals External News

Will Japan’s First IMCIVREE Approval in Hypothalamic Obesity Change Rhythm Pharmaceuticals’ (RYTM) Narrative - simplywall.st

news.google.com · 31 Aug 2026

Google News – Biopharma External News

HKEX Says Trading In Wuhan Yzy Biopharma H Shares Halted - TradingView

news.google.com · 31 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA approves Protagonist and Takeda’s drug for rare blood cancer - STAT

news.google.com · 31 Aug 2026

Google News – Clinical Trials External News

HiRO and Differentia Join Forces to Advance AI-Powered Clinical Trial Simulation and Digital Twins - BioPharma APAC

news.google.com · 31 Aug 2026

Google News – Clinical Trials External News

HiRO and Differentia Join Forces to Advance AI-Powered Clinical Trial Simulation and Digital Twins - BioPharma APAC

news.google.com · 31 Aug 2026

Google News – Biopharma External News

Biopharma firm AusperBio secures $120m Series C to advance chronic hepatitis B therapies - DealStreetAsia

news.google.com · 31 Aug 2026

Google News – Biopharma External News

African biopharma Minapharm receives up to £12m-plus to advance Bundibugyo Ebola vaccine - Laboratory News

news.google.com · 31 Aug 2026

Google News – Pharmaceuticals External News

Jazz Pharmaceuticals (JAZZ) Could Be 13% Undervalued On FDA Approval Of Ziihera - simplywall.st

news.google.com · 31 Aug 2026

Google News – Pharmaceuticals External News

Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-Democrat

news.google.com · 31 Aug 2026

Google News – Pharmaceuticals External News

Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - lincolnjournal.com

news.google.com · 31 Aug 2026

Google News – Pharmaceuticals External News

Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia - ir.arrowheadpharma.com

news.google.com · 30 Aug 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

How America Can Reduce Its Dependence on Chinese Active Pharmaceutical Ingredients (APIs) - Information Technology and Innovation Foundation

Forget GLP-1 stocks, baldness drugs are Wall Street’s next gold mine - The Japan Times

Cipla Pharma license cancellation: FDA withdraws order after HC raps it for going 'overboard' - pharma.economictimes.indiatimes.com

US FDA approves Takeda, Protagonist's drug for rare blood cancer - pharma.economictimes.indiatimes.com

Will Japan’s First IMCIVREE Approval in Hypothalamic Obesity Change Rhythm Pharmaceuticals’ (RYTM) Narrative - simplywall.st

HKEX Says Trading In Wuhan Yzy Biopharma H Shares Halted - TradingView

FDA approves Protagonist and Takeda’s drug for rare blood cancer - STAT

HiRO and Differentia Join Forces to Advance AI-Powered Clinical Trial Simulation and Digital Twins - BioPharma APAC

HiRO and Differentia Join Forces to Advance AI-Powered Clinical Trial Simulation and Digital Twins - BioPharma APAC

Biopharma firm AusperBio secures $120m Series C to advance chronic hepatitis B therapies - DealStreetAsia

African biopharma Minapharm receives up to £12m-plus to advance Bundibugyo Ebola vaccine - Laboratory News

Jazz Pharmaceuticals (JAZZ) Could Be 13% Undervalued On FDA Approval Of Ziihera - simplywall.st

Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-Democrat

Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - lincolnjournal.com

Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia - ir.arrowheadpharma.com